The state's effort to develop business ties between four of the leading biotechnology firms in Taiwan and Maryland's life sciences industry have resulted in over $100,000 in export business over the past three years. Meetings in August, the third collaborative event between the Department of Business Economic and Economic Development's Office of International Investment and Trade and the Taiwanese ROC-USA Business Council, have helped introduce the companies to their Taiwanese and U.S. counterparts.
Taiwanese biotech companies including, Adimmune, a human vaccine manufacturer; Simpson Biotech, a top bio-fermentation company; General Biologicals, an in vitro diagnostic device manufacturer; PhytoHealth, the first publicly traded Taiwan novel drug development company; and the Medical and Pharmaceutical Industry Technology and Development Center, Taiwan's pre-imminent non-profit biotechnology industry organization, are among the companies that have participated in the event.
Writer: Walaika Haskins
Source: Maryland Department of Business and Economic Development